Nutritional status in patients with COVID-19 and cancer: the experience of the National Cancer Institute in Mexico

被引:3
|
作者
Perez Camargo, Dana Aline [1 ,7 ]
Vargas Gutierrez, Gaspar [1 ]
Rivera Franco, Monica M. [6 ]
Labana Ramirez, Anabel [1 ]
Castro Herrera, Monserrat [1 ]
Urbalejo Ceniceros, Victor Itai [2 ]
Copca Mendoza, Erika Thalia [1 ]
Loyola Serrano, Osiris [1 ]
Baltazar Luna, Erendira [1 ]
Meneses Garcia, Abelardo [4 ]
Herrera Gomez, Angel [5 ]
Gonzalez Enciso, Aaron [3 ]
Sevilla Gonzalez, Maria de la Luz [7 ]
机构
[1] Inst Nacl Cancerol, Dept Nutr, Ave San Fernando 22,Belisario Dominguez Secc XVI, Mexico City 14080, DF, Mexico
[2] Inst Nacl Cancerol, Dept Hematol, Mexico City, DF, Mexico
[3] Inst Nacl Cancerol, Dept Surg, Mexico City, DF, Mexico
[4] Inst Nacl Cancerol, Dept Gen Directorship, Mexico City, DF, Mexico
[5] Inst Nacl Cancerol, Dept Med Directorship, Mexico City, DF, Mexico
[6] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Hematol & Oncol, Mexico City, DF, Mexico
[7] Inst Politecn Nacl, Fac Med, Postgrad & Res Dept, Mexico City, DF, Mexico
关键词
Body mass index; Cancer; COVID-19; Mortality; Nutrition;
D O I
10.20960/nh.03683
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: nutritional status might vary according to different underlying illnesses such as cancer or infectious diseases, including COVID-19. In this context, data from developing countries remain scarce. Objectives: the objective of this study was to assess the nutritional status and outcomes of Mexican cancer patients diagnosed with COVID-19 at a tertiary care center. Methods: this was a retrospective study including 121 consecutive cancer patients diagnosed with COVID-19 at the National Cancer Institute, Mexico City, during four months. Results: the most frequent oncological diagnoses were gynecological (19 %) and hematological (17 %). Most patients were overweight (35 %). In the univariate analysis, >= 65 years, intubation, hypoalbuminemia, high creatinine, lymphopenia, nutrition-impact symptoms, and ECOG 2-4 were statistically associated with lower survival. The median survival of the cohort was 41 days. Conclusions: to our best knowledge, this is the first study of its kind performed in Mexico, and as other studies from other regions, our results might aid in identifying cancer patients most at risk for severe COVID-19, and could be potentially useful to enhance public health messaging on self-isolation and social distancing among Mexican cancer patients.
引用
收藏
页码:1263 / 1268
页数:6
相关论文
共 50 条
  • [1] Initial report on hospitalized cancer patients with COVID-19 from the National Cancer Institute (NCI) COVID-19 in Cancer Patients Study (NCCAPS).
    Mark, Nicholas M.
    Best, Ana F.
    Khorana, Alok A.
    Pergam, Steven
    Mishkin, Grace E.
    Bowman, Melissa
    Denicoff, Andrea M.
    Rubinstein, Lawrence
    Shankar, Lalitha Krishna
    Doroshow, James H.
    Rini, Brian I.
    Korde, Larissa A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Cancer inpatients with COVID-19: A report from the Brazilian National Cancer Institute
    de Melo, Andreia C.
    Thuler, Luiz C. S.
    da Silva, Jesse L.
    de Albuquerque, Lucas Z.
    Pecego, Ana C.
    Rodrigues, Luciana de O. R.
    da Conceicao, Magda S.
    Garrido, Marianne M.
    Quintella Mendes, Gelcio L.
    Mendes Pereira, Ana Cristina P.
    Soares, Marcelo A.
    Viola, Joao P. B.
    PLOS ONE, 2020, 15 (10):
  • [3] Nutritional status of patients with COVID-19
    Im, Jae Hyoung
    Je, Young Soo
    Baek, Jihyeon
    Chung, Moon-Hyun
    Kwon, Hea Yoon
    Lee, Jin-Soo
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 100 : 390 - 393
  • [4] IMMUNOMETABOLIC STATUS OF COVID-19 CANCER PATIENTS
    Sica, A.
    Colombo, M. P.
    Trama, A.
    Horn, L.
    Garassino, M. C.
    Torri, V
    PHYSIOLOGICAL REVIEWS, 2020, 100 (04) : 1839 - 1850
  • [5] COVID-19 vaccination in gastrointestinal cancer patients receiving chemotherapy: A single institute experience
    Suenaga, Mitsukuni
    Yamauchi, Shinichi
    Masuda, Taiki
    Hanaoka, Marie
    Iwata, Noriko
    Sato, Yuya
    Tomii, Chiharu
    Tokunaga, Masanori
    Kinugasa, Yusuke
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [6] Initial reporting from the prospective National Cancer Institute (NCI) COVID-19 in Cancer Patients Study (NCCAPS).
    Korde, Larissa A.
    Best, Ana F.
    Gnjatic, Sacha
    Denicoff, Andrea M.
    Mishkin, Grace E.
    Bowman, Melissa
    Harris, Lyndsay
    Geiger, Ann M.
    McCaskill-Stevens, Worta J.
    Chanock, Stephen J.
    Spears, Patricia
    Rubinstein, Lawrence
    Mark, Nicholas M.
    Warner, Jeremy Lyle
    Allegra, Carmen Joseph
    Esbenshade, Adam J.
    Knopp, Michael V.
    Doroshow, James H.
    Rini, Brian I.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Nutritional status of cancer patients admitted for chemotherapy at the National Kidney and Transplant Institute
    Montoya, J. E.
    Domingo, F., Jr.
    Luna, C. A.
    Berroya, R. M.
    Catli, C. A.
    Ginete, J. K.
    Sanchez, O. S.
    Juat, N. J.
    Tiangco, B. J.
    Jamias, J. D.
    SINGAPORE MEDICAL JOURNAL, 2010, 51 (11) : 860 - 864
  • [8] Impact of COVID-19 on clinical practice and research in oncology in Singapore - experience of the National University Cancer Institute
    Soo, Ross A.
    ANNALS OF ONCOLOGY, 2021, 32 : S229 - S229
  • [9] Breast cancer surgery during the Covid-19 pandemic: a monocentre experience from the Regina Elena National Cancer Institute of Rome
    Fabio Pelle
    Sonia Cappelli
    Franco Graziano
    Loredana Piarulli
    Flavia Cavicchi
    Domenico Magagnano
    Assunta De Luca
    Roy De Vita
    Marcello Pozzi
    Maurizio Costantini
    Antonio Varanese
    Massimo Panimolle
    Pietro Paolo Gullo
    Maddalena Barba
    Patrizia Vici
    Enrico Vizza
    Francesco Cognetti
    Giuseppe Sanguineti
    Elena Saracca
    Gennaro Ciliberto
    Claudio Botti
    Journal of Experimental & Clinical Cancer Research, 39
  • [10] Breast cancer surgery during the Covid-19 pandemic: a monocentre experience from the Regina Elena National Cancer Institute of Rome
    Pelle, Fabio
    Cappelli, Sonia
    Graziano, Franco
    Piarulli, Loredana
    Cavicchi, Flavia
    Magagnano, Domenico
    De Luca, Assunta
    De Vita, Roy
    Pozzi, Marcello
    Costantini, Maurizio
    Varanese, Antonio
    Panimolle, Massimo
    Gullo, Pietro Paolo
    Barba, Maddalena
    Vici, Patrizia
    Vizza, Enrico
    Cognetti, Francesco
    Sanguineti, Giuseppe
    Saracca, Elena
    Ciliberto, Gennaro
    Botti, Claudio
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)